|
Cell Signaling Technology Inc
socs3 Socs3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/socs3/SOCS3+Rabbit+mAb/pm34774537-196-33-37 Average 95 stars, based on 1 article reviews
socs3 - by Bioz Stars,
2026-11
95/100 stars
|
Buy from Supplier |
|
Cusabio
recombinant mouse socs3 protein ![]() Recombinant Mouse Socs3 Protein, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/socs3/SOCS3/pmc05464880-123-0-12 Average 93 stars, based on 1 article reviews
recombinant mouse socs3 protein - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Proteintech
socs3 ![]() Socs3, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/socs3/SOCS3+Antibody/pmc12806337-266-119-120 Average 95 stars, based on 1 article reviews
socs3 - by Bioz Stars,
2026-11
95/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
anti socs3 antibody ![]() Anti Socs3 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/socs3/SOCS-3+Antibody/pm16822822-55-7-9 Average 94 stars, based on 1 article reviews
anti socs3 antibody - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
R&D Systems
socs 3 ![]() Socs 3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/socs3/Human%2FMouse+SOCS-3+Antibody/pmc04385752-122-23-24 Average 94 stars, based on 1 article reviews
socs 3 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Cusabio
elisa kits for socs3 ![]() Elisa Kits For Socs3, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/socs3/Human+suppressors+of+cytokine+signaling+3%2CSOCS-3+ELISA+Kit/pm40545471-74-1-11 Average 93 stars, based on 1 article reviews
elisa kits for socs3 - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Cyagen Biosciences
socs3fl ![]() Socs3fl, supplied by Cyagen Biosciences, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/socs3/Socs3/pm37578862-580-0-5 Average 91 stars, based on 1 article reviews
socs3fl - by Bioz Stars,
2026-11
91/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
prevalidated socs3 small interfering rnas ![]() Prevalidated Socs3 Small Interfering Rnas, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/socs3/SOCS-3+siRNA/pmc04067868-74-23-34 Average 93 stars, based on 1 article reviews
prevalidated socs3 small interfering rnas - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Novus Biologicals
socs3 ![]() Socs3, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/socs3/SOCS-3+Antibody/pmc03581908-339-30-32 Average 90 stars, based on 1 article reviews
socs3 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
OriGene
socs 3 ![]() Socs 3, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/socs3/SOCS3+(2-44)+Mouse+Monoclonal+Antibody/10__1677_slash_erc___10___0007-85-8-10 Average 90 stars, based on 1 article reviews
socs 3 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
OriGene
suitable socs3 ![]() Suitable Socs3, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/socs3/SOCS3+Human+shRNA+Lentiviral+Particle/us09511036-164-0-17 Average 90 stars, based on 1 article reviews
suitable socs3 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Addgene inc
cytokine signaling 3 socs3 pcmv socs ![]() Cytokine Signaling 3 Socs3 Pcmv Socs, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/socs3/pCMV+SOCS-3+(Plasmid+%2311486)/pmc09198438-83-5-17 Average 93 stars, based on 1 article reviews
cytokine signaling 3 socs3 pcmv socs - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Oncotarget
Article Title: SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction
doi: 10.18632/oncotarget.16504
Figure Lengend Snippet: (A) Heat map representation of qPCR array data about the expression levels of 84 genes involved in AA progression. Total RNA was extracted from human HF homogenates using Trizol reagent. The reverse transcription for mRNA was carried out using cDNA conversion kit. QPCR for assaying 84 genes expression was performed using a standard protocol from the SYBR Green Real-Time PCR Mix. The GAPDH expression was used as an internal control. Among them, the expression levels of SOCS3, Fas and Hes1 are significantly dysregulated in human AA tissues. * p < 0.05. ** p < 0.01. (B) qPCR analysis of SOCS3 level in 24 human AA tissues and pair non-AA tissues. The SOCS3 transcripts were expressed at lower levels in most AA tissues (21/24) compared with the non-AA tissues of the same donor. (C) qPCR analysis of SOCS3 level in 35 skin tissues of human AA and 32 healthy control. The data showed a significantly lower SOCS3 expression in skin tissues of AA patients than healthy skin tissues. (D) qPCR analysis of SOCS3 level in C3H/HeJ AA mice and C3H/HeJ control mice (n = 9). SOCS3 mRNAs were lowly expressed in alopecic skin of C3H/HeJ AA mice compared with control mice. * p < 0.05. ** p < 0.01.
Article Snippet:
Techniques: Expressing, Reverse Transcription, SYBR Green Assay, Real-time Polymerase Chain Reaction, Control
Journal: Oncotarget
Article Title: SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction
doi: 10.18632/oncotarget.16504
Figure Lengend Snippet: C3H/HeJ mice that spontaneously developed AA were euthanized, and full thickness skin grafts were removed and grafted to C3H/HeJ mice. Mice then were treated beginning the day of grafting (n = 9 mice/group). Recombinant mouse SOCS3 protein or IgG control was administrated by i.p. injection (250 μg) two times weekly for 14 weeks. (A) The onset of alopecia was inhibited by treatment of SOCS3. (B) Time course of onset of AA in SOCS3–treated mice and control mice was shown as weeks after grafting. (C and D) Migration of CFSE-labeled CD4+ / CD8+T cells into AA skin grafts was evaluated by immunofluorescent microscopy. The results are representative of five independent experiments. (E) Immunohistochemical staining of skin biopsies for assaying CD4 and CD8 expression in skin of mice treated with SOCS3 or IgG control. The results are representative of seven independent experiments. (F) The ability of SOCS3-treated skin cells to stimulate purified T cell proliferation was assayed in vitro . Scale bars =100 μm. * p < 0.05.
Article Snippet:
Techniques: Recombinant, Control, Injection, Migration, Labeling, Microscopy, Immunohistochemical staining, Staining, Expressing, Purification, In Vitro
Journal: Oncotarget
Article Title: SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction
doi: 10.18632/oncotarget.16504
Figure Lengend Snippet: (A) CD8+ T cells were isolated from SDLNs of SOCS3-treated C3H/HeJ AA mice and were used to assay the level of CD44 and CD62L. Flow cytometry data showed that 15.8% of CD8+ T cells from SDLNs were CD44 high CD62L low in C3H/HeJ AA mice, whereas SOCS3 treatment markedly decreases CD44 high CD62L low effector memory CD8+ T cells. Data are representative of three independent experiments. Isotype-matched, directly conjugated primary Abs were additionally used to confirm Ab specificity for all markers (data not shown). (B) Percentage of CD44 high CD62L low effector memory CD8+ T cells was quantitated by flow cytometric analysis. Data are mean ± SD of three independent experiments. (C) CD8+ T cells were isolated from skins of SOCS3-treated C3H/HeJ AA mice and were used to assay the percentage of IFN-γ-producing CD8+ T cells. (D) Percentage of IFN-γ-producing CD8+ T cells was quantitated by flow cytometric analysis. Data are mean ± SD of three independent experiments. (E and F) IFN-γ level in SOCS3-treated AA skin was evaluated by immunofluorescent microscopy. Data are mean ± SD of three independent experiments. (G) IFN-γ mRNA level in the skin of grafted recipients was assayed after treatment with SOCS3 or IgG control (n = 6 mice/group). SOCS3-treated group possessed a lower ability to produce IFN-γ compared with control. (H) ELISA analysis of IFN-γ production. The amount of IFN-γ produced by T cells stimulated with SOCS3-treated skin cells was decreased compared with that of cells stimulated with IgG-treated skin cells. Scale bars =100 μm.*# p < 0.05.
Article Snippet:
Techniques: Isolation, Flow Cytometry, Microscopy, Control, Enzyme-linked Immunosorbent Assay, Produced
Journal: Oncotarget
Article Title: SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction
doi: 10.18632/oncotarget.16504
Figure Lengend Snippet: (A) Immunohistochemical staining for assaying MHC I expression in skin of C3H/HeJ AA mice treated with SOCS3 or IgG control. The expression level of MHC I in C3H/HeJ AA mice was upregulated compared with C3H/HeJ mice, whereas SOCS3 treatment markedly inhibited MHC I expression in C3H/HeJ AA mice. Data are representative of seven independent experiments. (B) The MHC I mRNA levels were assayed in skins of C3H/HeJ, C3H/HeJ AA and SOCS3-treated C3H/HeJ AA mice (n = 13 mice/group). (C) Skin cells from C3H/HeJ AA mice were treated with TNF-α, IFN-γ and SOCS3, and the expression of MHC I was analyzed using qPCR. TNF-α and IFN-γ upregulated MHC I expression on skin cells, whereas TNF-α/IFN-γ-induced MHC I expression was markedly inhibited by SOCS3 treatment. (D) Immunofluorescent staining for assaying Fas expression in skin of C3H/HeJ, C3H/HeJ AA and SOCS3-treated C3H/HeJ AAmice. Data are representative of three independent experiments. (E) The Fas mRNA levels were assayed in skins of C3H/HeJ, C3H/HeJ AA and SOCS3-treated C3H/HeJ AA mice (n = 13 mice/group). (F) Skin cells from C3H/HeJ AA mice were treated with TNF-α, IFN-γ and SOCS3, and the expression of Fas was analyzed using qPCR. Scale bars =100 μm.*# p < 0.05.
Article Snippet:
Techniques: Immunohistochemical staining, Staining, Expressing, Control
Journal: Oncotarget
Article Title: SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction
doi: 10.18632/oncotarget.16504
Figure Lengend Snippet: CD8+ T cells isolated from SDLNs of AA-affected mice were subcutaneously injected into normal C3H/HeJ recipients. Mice then were subcutaneously injected beginning the day of injection with 250 μg of SOCS3 or IgG (n = 9 mice/group). (A) The onset of alopecia was inhibited by treatment of SOCS3. (B) Time course of onset of AA in SOCS3–treated mice and control mice was shown as weeks after CD8+ T cells injection. (C) CD8+ T cells were isolated from skins of SOCS3-treated C3H/HeJ AA mice and were used to assay the percentage of IFN-γ-producing CD8+ T cells. Data are representative of three independent experiments. (D) Percentage of IFN-γ-producing CD8+ T cells was quantitated by flow cytometric analysis. (E) CD8+ T cells were isolated from SDLNs of SOCS3-treated C3H/HeJ AA mice and were used to assay the level of CD44 and CD62L. SOCS3 treatment markedly decreases CD44 high CD62L low effector memory CD8+ T cells. Data are representative of three independent experiments. (F) Percentage of CD44 high CD62L low effector memory CD8+ T cells was quantitated by flow cytometric analysis. (G) IFN-γ mRNA level in the skin of injected recipients was assayed after treatment with SOCS3 or IgG control (n = 7 mice/group). (H) The Fas and MHC I mRNA level in the skin of injected recipients was assayed after treatment with SOCS3 or IgG control (n = 7 mice/group). * p < 0.05.
Article Snippet:
Techniques: Isolation, Injection, Control
Journal: Oncotarget
Article Title: SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction
doi: 10.18632/oncotarget.16504
Figure Lengend Snippet: (A) Detection of Fas expression on HF in human AA scalp and healthy control by immunofluorescence analysis. Data are representative of seven independent experiments. (B) qPCR analysis of Fas level in 31 skin tissues of human AA and healthy control. The data showed a significantly higher Fas expression in the skin tissues of AA patients than healthy skin tissues. (C) The negative association between SOCS3 level and Fas level was measured in 31 human alopecic skin tissues. (D) Detection of MHC I expression on HF in human AA scalp and normal control by immunofluorescence analysis. Data are representative of seven independent experiments. (E) qPCR analysis of MHC I level in 30 skin tissues of human AA and healthy control. The data showed a significantly higher MHC I expression in the skin tissues of AA patients than healthy skin tissues. (F) The negative association between SOCS3 level and MHC I level was measured in 30 human alopecic skin tissues. Scale bars =100 μm. * p < 0.05.
Article Snippet:
Techniques: Expressing, Control, Immunofluorescence
Journal: Advanced Science
Article Title: The Crosstalk Between CRL5 and APC/C E3 Ligases Regulates Metastasis and Chemosensitivity of Cancer Cells
doi: 10.1002/advs.202512652
Figure Lengend Snippet: APC11 depletion promotes CUL5 neddylation but stabilizes integrin β1. a) Immunoblot of indicated proteins in PLC/PRF/5, Hep3B, and PANC‐1 cells transfected with siRNA targeting APC11 or with a scrambled control siRNA. b) Co‐IP of transfected FLAG‐CUL5 and endogenous CAND1, COPS5, UBE2F or SAG in HEK293 cells transfected with indicated siRNA oligos. c) Co‐IP of endogenous CUL5 with UBE2F or APC11 in A549 cells transfected with indicated siRNA oligos. d) Immunoblot of CUL5 in A549 and PLC/PRF/5 cells transfected with indicated siRNA oligos. e) The stability of SOCS3 and integrin β1 in A549 and MIA PaCa‐2 cells upon APC11 knockdown. A549 and MIA PaCa‐2 cells were transfected with indicated siRNA oligos for 72 h and then treated with 100 µg mL −1 CHX for the indicated time periods, followed by IB analysis. Densitometry quantifications were performed with ImageJ, and the decay curves are shown (right). Data are presented as mean ± SEM, n = 3. For statistical analysis, significances were determined by Student's t ‐test. * p < 0.05, ** p < 0.01, *** p < 0.001. f) Diagram illustrating how APC11 depletion promotes CUL5 neddylation and leads to integrin β1 accumulation.
Article Snippet: [ ] The following antibodies were used: ACTIN (Sigma–Aldrich, A5441), FLAG (Sigma–Aldrich, F1804), FLAG (Sigma–Aldrich, F7425), GFP (Santa Cruz, sc‐9996), MYC (Santa Cruz, sc‐789), APC2 (Cell Signaling Technology, 12301), APC8 (Cell Signaling Technology, 15100), APC10 (Cell Signaling Technology, 14807), APC11 (Cell Signaling Technology, 14090), APC11 (Santa Cruz, sc‐517142), SAG (Proteintech, 11905‐1‐AP), RBX1 (Proteintech, 14895‐1‐AP), CUL1 (Santa Cruz, sc‐11384), CUL5 (Abcam, ab184177), CUL5 (Santa Cruz, sc‐373822), CAND1 (Abcam, ab183748), integrin β1 (Cell Signaling Technology, 34 971), p‐SRC (Y416) (Cell Signaling Technology, 6943), ATM (Cell Signaling Technology, 2873), Cyclin B1 (Cell Signaling Technology, 4138), RPB1 (Cell Signaling Technology, 14958), EGFR (Cell Signaling Technology, 4267), DEPTOR (Cell Signaling Technology, 11 816), NOXA (Millipore, OP180), UBE2F (Proteintech, 17056‐1‐AP), COPS5 (Cell Signaling Technology, 6895),
Techniques: Western Blot, Transfection, Control, Co-Immunoprecipitation Assay, Knockdown
Journal: The Journal of Immunology Author Choice
Article Title: Podocytes Regulate Neutrophil Recruitment by Glomerular Endothelial Cells via IL-6–Mediated Crosstalk
doi: 10.4049/jimmunol.1300229
Figure Lengend Snippet: SOCS3-mediated downregulation of neutrophil recruitment in cocultures of GEnCs and podocytes. ( A ) Detection of SOCS3 mRNA in TNF-α (100 U/ml)–stimulated cultures of GEnCs (filled bars) and podocytes (open bars) by quantitative PCR following SOCS3 knockdown with three different oligomers (labeled A [mixture of three oligomers] and B and C [individual oligomers]) or a scrambled control. Lipofectamine presence is indicated, whereas “untreated” indicates absence of Lipofectamine, scrambled control, or SOCS oligomers. Data are minimum to maximum ( n = 3–6). A Friedman test compared the effect of SOCS3 knockdown ( p < 0.05). * p < 0.05 comparing controls within cultures by a Dunnett post hoc test. ( B ) Western blotting confirming the SOCS3 protein knockdown in GEnCs and podocytes compared with controls (untreated cultures, Lipofectimine-treated cultures, and scrambled RNA-treated cultures). β-actin was used as loading control. ( C ) Neutrophil recruitment in cocultures (open bars) and GEnC monoculture (filled bars) with SOCS3 knockdown (−/−) with three different oligomers (labeled A [mixture of three oligomers] and B and C [individual oligomers]) or a scrambled control. Lipofectamine presence is indicated, whereas “untreated” indicates absence of Lipofectamine, scrambled control, or SOCS oligomers. Neutrophil recruitment in cocultures was also tested with SOCS3 knockdown in only one cell type. Neutrophil recruitment was assessed in TNF-α (100 U/ml)–treated cultures at 1 h. Data are minimum to maximum of recruited cells ( n = 3–7). A Friedman test compared the effect of SOCS3 knockdown ( p < 0.05). * p < 0.05, ** p < 0.01 comparing with controls by a Dunnett post hoc test.
Article Snippet: Cells were grown in RPMI 1640 with no antibiotics and subconfluent GEnCs, and podocytes were transfected with 25 nM/l of three target-specific commercial
Techniques: Real-time Polymerase Chain Reaction, Knockdown, Labeling, Control, Western Blot
Journal: The Journal of Immunology Author Choice
Article Title: Podocytes Regulate Neutrophil Recruitment by Glomerular Endothelial Cells via IL-6–Mediated Crosstalk
doi: 10.4049/jimmunol.1300229
Figure Lengend Snippet: Effect of SOCS3 deletion in the upregulation of genes that support neutrophil recruitment in cocultures. Quantification of expression of genes ( A ) CXCL5, ( B ) DARC, ( C ) IL-6, and ( D ) TNFR1 that supported the neutrophil recruitment in cocultures, prior to and after depletion of SOCS3, in GEnCs and podocytes from mono- and cocultures compared with monocultures without SOCS3 knockdown. Data are expressed as fold change to TNF-α–stimulated monocultures ( n = 5). * p < 0.05, ** p < 0.01, *** p < 0.0001 comparing the difference in gene expression with the stimulated monocultures without SOCS3 knockdown by an unpaired t test.
Article Snippet: Cells were grown in RPMI 1640 with no antibiotics and subconfluent GEnCs, and podocytes were transfected with 25 nM/l of three target-specific commercial
Techniques: Expressing, Knockdown, Gene Expression
Journal: Proceedings of the National Academy of Sciences of the United States of America
Article Title: Modulation of AgRP-neuronal function by SOCS3 as an initiating event in diet-induced hypothalamic leptin resistance
doi: 10.1073/pnas.1218284110
Figure Lengend Snippet: HFD-induced SOCS3 up-regulation occurs in AgRP neurons before POMC and other hypothalamic cells. (A) Mice were fed with a LFD or HFD for 2 d or 2 wk. Fed animals were perfused and immunofluorescence analysis was performed to examine SOCS3 expression in the hypothalamus. POMC neurons are identified by ACTH immunoreactivity, and AgRP neurons are identified by GFP signals. (B) SOCS3 intensity was increased in AgRP neurons, but not in POMC neurons, in mice after 2 d of HFD compared with mice fed with a LFD. n = 4–5 mice per group. (C) The numbers of SOCS3-positive AgRP or POMC neurons were not altered in mice fed with a HFD for 2 d compared with mice fed LFD. However, the number of SOCS3-positive POMC neurons was increased significantly after 2 wk of HFD. n = 4–5 mice per group. (D) Number of SOCS3-positive cells outside the arcuate nucleus (ARC) was increased in mice fed with a HFD for 2 wk. n = 4–5 mice per group. *P ≤ 0.05 and **P ≤ 0.01 as determined by a one-way ANOVA with a Bonferroni post hoc test in C and D, and a Student t test was used to compare LFD and 2-d HFD in B. Data represent mean ± SEM. 3V: third ventricle.
Article Snippet: Sections were incubated with primary antibody against pSTAT3 (1:200; Cell Signaling), ACTH (1:400; National Hormone & Peptide Program), or albumin (1:250; Thermo Scientific Pierce) overnight at 4 °C or against
Techniques: Immunofluorescence, Expressing
Journal: Proceedings of the National Academy of Sciences of the United States of America
Article Title: Modulation of AgRP-neuronal function by SOCS3 as an initiating event in diet-induced hypothalamic leptin resistance
doi: 10.1073/pnas.1218284110
Figure Lengend Snippet: Expression of SOCS3 is reversibly regulated in the AgRP neurons in response to acute changes of dietary conditions. (A) Female mice with Npy-GFP reporter were fed with a LFD, a HFD for 2 d, or a HFD for 2 d followed by a LFD for 1 d. Fed animals were perfused and immunofluorescence analysis was performed to examine SOCS3 expression in the hypothalamus. AgRP neurons are identified by GFP signals. (B) SOCS3 intensity was increased in AgRP neurons in mice fed a HFD for 2 d compared with mice fed a LFD. In mice fed a HFD for 2 d followed by 1 d of LFD, the SOCS3 intensity returned to levels comparable to in mice fed a LFD. n = 3–4 mice per group.*P ≤ 0.05 as determined by a one-way ANOVA with a Bonferroni post hoc test. n.s., not significant. Data represent mean ± SEM. 3V: third ventricle.
Article Snippet: Sections were incubated with primary antibody against pSTAT3 (1:200; Cell Signaling), ACTH (1:400; National Hormone & Peptide Program), or albumin (1:250; Thermo Scientific Pierce) overnight at 4 °C or against
Techniques: Expressing, Immunofluorescence
Journal: Proceedings of the National Academy of Sciences of the United States of America
Article Title: Modulation of AgRP-neuronal function by SOCS3 as an initiating event in diet-induced hypothalamic leptin resistance
doi: 10.1073/pnas.1218284110
Figure Lengend Snippet: Transgenic SOCS3 up-regulation in AgRP neurons results in metabolic phenotypes mimicking those seen after short-term consumption of a high-fat diet. (A) Caloric intake during the light and dark cycle in 12-wk-old control mice (n = 16) and AgRP-SOCS3-OE mutant mice (n = 5) as measured by CLAMS. (B) Oxygen consumption was measured in 12-wk-old mice and the values were normalized to lean body mass of each mouse. Control mice n = 16, mutant mice n = 5. (C) Body weight of control mice (n = 20–74) and AgRP-SOCS3-OE mutant mice (n = 14–39) on chow diet at indicated ages. (D) Lean mass and fat mass as analyzed by DEXA in 25- to 35-wk-old control mice (n = 36) and AgRP-SOCS3-OE mutant mice (n = 21). (E) Weight of dissected fat pads from 30- to 40-wk-old control mice (n = 18) and AgRP-SOCS3-OE mutant mice (n = 9). (F) Plasma leptin levels under fed conditions for 30- to 42-wk-old control mice (n = 11) and AgRP-SOCS3-OE mutant mice (n = 9). (G) Eight-week-old control (n = 7) and mutant (n = 5) mice were injected with vehicle (saline) or leptin (2.5 mg/kg body weight), and 24-h food intake was measured. (H) Liver triglyceride in 30- to 40-wk-old control mice (n = 8) and AgRP-SOCS3-OE mutant mice (n = 8). (I and J) Blood glucose and plasma insulin after 6 h fast in 20- to 30-wk-old control mice (n = 9) and AgRP-SOCS3-OE mutant mice (n = 6). (K) AgRP-SOCS3-OE (n = 11) and control mice (n = 22) at 12 wk of age were fasted for 6 h, and injected with 2.5 g/kg glucose. Glucose levels were measured from tail blood using a glucometer. (L) Thirteen-week-old control mice (n = 17) and AgRP-SOCS3-OE mutant mice (n = 11) were fasted overnight, and injected with 1 U/kg insulin. Glucose levels were measured from tail blood using a glucometer. Data represent mean± SEM *P < 0.05, **P ≤ 0.01, ***P ≤ 0.001 between control and mutant mice as determined by two-way repeated measures ANOVA (A–C, K, and L) and Student t tests (D–J).
Article Snippet: Sections were incubated with primary antibody against pSTAT3 (1:200; Cell Signaling), ACTH (1:400; National Hormone & Peptide Program), or albumin (1:250; Thermo Scientific Pierce) overnight at 4 °C or against
Techniques: Transgenic Assay, Control, Mutagenesis, Clinical Proteomics, Injection, Saline
Journal: Proceedings of the National Academy of Sciences of the United States of America
Article Title: Modulation of AgRP-neuronal function by SOCS3 as an initiating event in diet-induced hypothalamic leptin resistance
doi: 10.1073/pnas.1218284110
Figure Lengend Snippet: AgRP neurons situated outside the BBB are primary targets of SOCS3 up-regulation after short-term consumption of a HFD. (A) Transgenic mice expressing Npy-GFP were fed a HFD for 2 d or a matched LFD. Fed animals were perfused and immunofluorescence analysis was performed to examine SOCS3 (green) and albumin (red) expression in the hypothalamus. Npy-GFP (blue) was used to identify AgRP neurons, and albumin was used to identify cells outside the BBB. (B) Two days of HFD increased the SOCS3 intensity in AgRP neurons situated outside the BBB. In contrast, feeding a HFD for 2 d did not increase the SOCS3 intensity in AgRP neurons situated inside the BBB. n = 4–5 mice per group. *P ≤ 0.05 between LFD and 2 d HFD as determined by a two-way ANOVA with a Bonferroni post hoc test. n.s., not significant. Data represent mean ± SEM. 3V: third ventricle.
Article Snippet: Sections were incubated with primary antibody against pSTAT3 (1:200; Cell Signaling), ACTH (1:400; National Hormone & Peptide Program), or albumin (1:250; Thermo Scientific Pierce) overnight at 4 °C or against
Techniques: Transgenic Assay, Expressing, Immunofluorescence